UK Genetic Testing Market: Navigating the Regulatory Environment and the Adoption of Personalized Medicine
The UK Genetic Testing Market is positioned at the forefront of the global personalized medicine revolution, benefiting from the infrastructure and research capabilities of the National Health Service (NHS) and leading academic institutions. Market growth is being propelled by the increasing application of genetic testing across various medical fields, including oncology (e.g., tumor profiling), prenatal screening, and rare disease diagnosis. The market is actively integrating advanced sequencing technologies, such as Next-Generation Sequencing (NGS), which allows for comprehensive, rapid, and cost-effective analysis of multiple genes.

